WHO Mapping of manufacturers of GLP-1 RA (glucagon-like peptide-1 receptor agonists) manufacturers

WHO
WHO Mapping of manufacturers of GLP-1 RA (glucagon-like peptide-1 receptor agonists) manufacturers Request for information

Reference: WHO-SHQ-RFI-26-5005
Beneficiary countries or territories: Multiple destinations (see the Countries or territories tab)
Published on: 13-Feb-2026
Deadline on: 16-Apr-2026 23:59 (GMT 1.00)

Description

Announcement 17 March 2026: the deadline of this RFI was extended from 19 March, 23:59 hours, Geneva time (GMT+1) to 16 April 2026, 23:59 hours, Geneva time (GMT+1)

This Request For Information (RFI) is to map the manufacturers having GLP1-RA in their portfolio and understanding their regulatory strategy for low- and middle-income countries and information on production capacity, if possible.

See detailed RFI document and submission instructions under “Documents” below.   

Please note: it is NOT necessary to click on “Express Interest” on the top right-hand side of the screen. In order to inform WHO that you are interested in participating in this Request For Information, please follow the provisions of the RFI document below.